Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)
Public ClinicalTrials.gov record NCT00093262. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to establish the efficacy of of clevidipine versus placebo in treating postoperative hypertension. Approximately 100 patients with postoperative hypertension undergoing coronary artery bypass grafting (CABG), off-pump coronary artery bypass (OPCAB) or minimally invasive direct coronary artery bypass (MIDCAB) surgery and/or valve replacement/repair procedures were anticipated to be randomly assigned to one of two treatment groups: clevidipine or placebo.
Study identification
- NCT ID
- NCT00093262
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 206 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2003
- Primary completion
- Sep 30, 2004
- Completion
- Sep 30, 2004
- Last update posted
- May 7, 2014
2003 – 2004
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Discovery Alliance - Mobile Infirmary Medical Center | Mobile | Alabama | 36602 | — |
| Keck School of Medicine, University of Southern California | Los Angeles | California | 90033 | — |
| Huntington Memorial Hospital | Pasadena | California | 91109 | — |
| Stanford University School of Medicine | Stanford | California | 94305-5640 | — |
| Emory Hospital | Atlanta | Georgia | 30322 | — |
| Heart Care Research Foundation | Blue Island | Illinois | 60406 | — |
| MacNeal Hospital | Glencoe | Illinois | 60022 | — |
| Wesley Medical Center | Wichita | Kansas | 67214 | — |
| St. Lukes Hospital | Kansas City | Missouri | 64111 | — |
| International Heart Institute | Missoula | Montana | 59802 | — |
| Mt. Sinai Medical Center | New York | New York | 10029-6574 | — |
| Columbia University - College of Physicians and Surgeons | New York | New York | 10032 | — |
| Carolinas Medical Center | Charlotte | North Carolina | 28203 | — |
| Discovery Alliance - Methodist Hospital / Diagnostic West Pavillion | Houston | Texas | 77030 | — |
| Medical College of Wisconsin VAMC - Milwaukee | Milwaukee | Wisconsin | 53295 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00093262, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2014 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00093262 live on ClinicalTrials.gov.